Literature DB >> 4356460

Direct immunofluorescence test for the diagnosis of genital herpesvirus infections.

S J Rubin, R D Wende, W E Rawls.   

Abstract

Herpetic lesions of the genitalia may be confused clinically with other ulcerative, genital lesions. Direct immunofluorescence (FA) provides a rapid method of diagnosis, and the utility of this method for the diagnosis of genital ulcers was examined. One hundred and ten patients with genital lesions were examined by darkfield for syphilis and by FA and culture for herpes simplex virus (HSV) infections. Satisfactory samples were obtained from 102 patients, of which 81 were clinically suspected cases of HSV. Acetone-fixed slides of scrapings of ulcerative lesions were stained with conjugated antiserum prepared in rabbits against HSV type 2. HSV was isolated from 73% of specimens of suspected herpetic lesions, and 77% of these specimens were positive by FA. Nine percent were positive by FA only and these were not thought to represent false positives. Five percent were positive by culture only. A comparison of clinical diagnoses with laboratory findings revealed that 4% of the cases were misdiagnosed when only the clinical evaluation was considered. The data suggest that the inclusion of a diagnostic FA test for HSV along with the darkfield examination may be useful for differentiating the etiological agents of ulcerative, genital lesions.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4356460      PMCID: PMC379793          DOI: 10.1128/am.26.3.373-375.1973

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  7 in total

1.  HERPES SIMPLEX. A STATISTICAL AND CLINICAL INVESTIGATION BASED ON 669 PATIENTS.

Authors:  U EILARD; L HELLGREN
Journal:  Dermatologica       Date:  1965

2.  Rapid diagnosis of herpes simplex virus infections with fluorescent antibody.

Authors:  J Z BIEGELEISEN; L V SCOTT; V LEWIS
Journal:  Science       Date:  1959-03-06       Impact factor: 47.728

3.  Rapid identification and typing of herpes simplex virus types 1 and 2 by a direct immunofluorescence technique.

Authors:  A Nahmias; I DelBuono; J Pipkin; R Hutton; C Wickliffe
Journal:  Appl Microbiol       Date:  1971-09

4.  A rapid diagnostic aid for herpesvirus hominis infections in dermatology.

Authors:  M M Black; J McQuillin; P S Gardner
Journal:  Dermatologica       Date:  1972

5.  Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease.

Authors:  A J Nahmias; W R Dowdle; Z M Naib; W E Josey; D McLone; G Domescik
Journal:  Br J Vener Dis       Date:  1969-12

6.  Biological markers for differentiation of herpes-virus strains of oral and genital origin.

Authors:  M E Figueroa; W E Rawls
Journal:  J Gen Virol       Date:  1969-03       Impact factor: 3.891

7.  Rapid diagnosis of herpesvirus hominis infections in superficial lesions by immunofluorescent antibody technics.

Authors:  P S Gardner; J McQuillin; M M Black; J Richardson
Journal:  Br Med J       Date:  1968-10-12
  7 in total
  4 in total

1.  Identification and typing of herpes simplex viruses with monoclonal antibodies.

Authors:  N Balachandran; B Frame; M Chernesky; E Kraiselburd; Y Kouri; D Garcia; C Lavery; W E Rawls
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

2.  Comparison of direct immunofluorescence and direct immunoperoxidase procedures for detection of herpes simplex virus antigen in lesion specimens.

Authors:  N J Schmidt; J Dennis; V Devlin; D Gallo; J Mills
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

3.  Clinical evaluation of commercial conjugates for direct immunofluorescence of herpes simplex virus.

Authors:  J G Gittzus; S J Rubin
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

4.  Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens.

Authors:  N J Schmidt; D Gallo; V Devlin; J D Woodie; R W Emmons
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.